Do You Have to Take a GLP-1 Forever? An Honest Answer

For most people, the honest answer is that a GLP-1 medication works while you are taking it and stops working when you stop. Obesity is a chronic condition, and Canadian obesity guidelines treat medication for it the way they treat medication for high blood pressure: something used long term when it is working, rather than a course you finish. In that sense, "indefinitely" is closer to the truth than "a few months."

But "forever" is the wrong word for what is actually being decided, and the difference matters more than it sounds. Indefinite is not the same as unchangeable, and a treatment plan is not a life sentence.

What happens when people stop

Three large trials give a reasonably clear picture, and it makes for uncomfortable reading.

In the extension of the STEP 1 trial, participants who had lost an average of roughly 17% of their body weight on semaglutide regained about two-thirds of that loss during the year after treatment and lifestyle support ended. Most of the improvements in blood pressure, blood sugar and cholesterol drifted back toward where they started as well.

The SURMOUNT-4 trial found the same pattern with tirzepatide. Among the 308 participants who had lost at least 10% during the 36-week lead-in and were then switched to placebo, most regained a substantial share of what they had lost over the following year, and the cardiometabolic gains reversed alongside the weight.

The mirror image gets discussed far less. STEP 5 followed people for two years on continued semaglutide. Average weight loss reached around 15% and stayed there through the second year rather than creeping back.

Averages hide a great deal. Some people in these trials held most of their loss after stopping and some regained all of it, and trial participants receive structured support not always available outside a study. None of this predicts what will happen to any individual, including you.

Why the weight comes back

The mechanism matters here, because it changes how the whole question feels.

After a substantial weight loss, the body does not settle at the new number and accept it. Energy expenditure falls somewhat, and the hormones that govern hunger and fullness shift in the direction of eating more. Researchers who tracked those hormones a full year after a supervised weight loss found they had not returned to pre-weight-loss levels, and neither had hunger.

That is the biology a GLP-1 medication pushes back against. Remove the medication and the pressure is still there: a body actively defending a higher weight, without the tool that was helping counter it.

This is why the Canadian Adult Obesity Clinical Practice Guidelines describe obesity as a complex chronic disease rather than a lifestyle problem, and why the 2025 pharmacotherapy update recommends that obesity medication be used long term when it is effective, specifically to avoid regain and the loss of the health improvements that came with it. The Canadian Medical Association recognized obesity as a chronic disease in 2015.

Regain after stopping is what removing a treatment for a chronic condition does. It is not evidence of weak character, and it is not proof the medication was a waste of money.

Why "forever" is the wrong word

The word usually carries three different fears bundled together.

The first is dependency. Needing ongoing treatment for an ongoing condition is not the same as dependency in the sense people fear. Nobody describes a person taking a statin or a blood pressure tablet as dependent on it. The discomfort attached to weight medication comes from a long-standing belief that body weight ought to be manageable by effort alone. The evidence does not support it, and Obesity Canada has spent years documenting the harm that belief causes.

The second is that the plan can never change. It can. "Long term, when effective" is the guideline wording, and the second half of that phrase does real work. If a medication is not working, or the side effects are not tolerable, continuing it indefinitely is not what the guidelines recommend either. Every prescription is reviewable, and the review belongs to you and your prescriber together.

There is early interest in whether less frequent injections at the same dose can hold weight loss after an initial period of treatment. What has been published is very small: a two-patient report with pharmacokinetic modelling, and a retrospective series of 30 people. There are no established protocols for stretching the interval, and it is not something to attempt independently. It is a conversation for whoever prescribes your medication.

The third is cost — the most concrete of the three.

Most people do not stay on a GLP-1 long term

Real-world data consistently show a large share of people stop within the first year, though persistence has improved as access widened.

When researchers looked at why, in a US clinical practice study of people who discontinued semaglutide or tirzepatide within a year, cost and insurance barriers accounted for nearly half of all discontinuations. Inability to tolerate side effects and medication shortages made up most of the rest. Only a small fraction stopped because the medication was not working.

Coverage in Canada works differently and varies between private plans and provinces, so those proportions do not transfer directly. The pattern does. Almost nobody stops a medication that is helping them because they lost interest.

What the alternatives to indefinite medication actually are

There is no single right answer, and what fits depends on why the question is being asked. If cost is the driver, the answer differs from the side-effect answer.

Staying on it, in some form

For a chronic condition, continuing effective treatment is the ordinary path rather than the exception. That might mean the same medication at the same dose, a different dose, or a different medication entirely. Health Canada has authorized five medications for general chronic weight management — orlistat, liraglutide, naltrexone-bupropion, semaglutide and tirzepatide — and they do not all work the same way, cost the same, or feel the same to take. The Sleeve Clinic prescribes and co-manages weight-management medication alongside surgery, so staying on treatment can be a plan made here rather than a reason to look elsewhere.

Structured non-surgical support

Dietitian-led nutrition support, treatment for sleep and mental health, behavioural therapy and strength-focused activity all matter, alongside a medication or on their own. Protein intake and resistance training deserve attention during any rapid weight loss, because a share of what is lost is lean tissue. Published estimates of how much vary widely, from roughly 15% to 60% of total weight lost across studies, and the review reporting that range reads the change as an adaptive one.

Bariatric surgery

For some people surgery fits. For others it does not, and that is a clinical judgment rather than a matter of how badly someone wants it.

What surgery changes, and what it does not

Sleeve gastrectomy is not an exit from chronic-disease management. It is a different long-term treatment for the same condition, working through changed stomach anatomy and altered hunger and fullness signalling rather than through a weekly injection. The practical difference is that those changes do not depend on a monthly prescription.

The trade-offs belong in the same sentence. It is an operation with surgical risks. It requires permanent changes to how you eat, ongoing vitamin supplementation and long-term follow-up with blood work. Outcomes vary between people, and weight regain can occur in the years afterwards, which is why follow-up is built into bariatric care rather than treated as optional. Some people use a weight-management medication after surgery as part of a longer-term plan, and that is a clinical decision made individually.

If you are considering surgery while taking a GLP-1, The Sleeve Clinic's instruction is that the medication stops before the operation, and stops at least two weeks beforehand. Published multi-society guidance leaves more room than that, allowing some patients to continue with precautions after an individual risk assessment, and practice varies between centres. The clinic's protocol is deliberately the more conservative of the two, and it is the one that applies to an operation here. Your surgical and anaesthesia team confirms the exact date to stop when your surgery is booked.

Wanting to stop a medication does not by itself make someone a surgical candidate. Eligibility depends on an individual assessment covering your health history, other conditions, medication history, eating patterns and mental health. Where a GLP-1 has already brought your weight down, that assessment looks at your current BMI, the highest BMI you have documented and the trajectory across both, rather than at today's number alone. The clinic's published criteria are for first-time bariatric surgery candidates, so a sleeve or bypass already performed at another centre sits outside what it takes on. If you would rather see roughly where you stand before speaking to anyone, the online eligibility check runs in under two minutes; if you would rather ask a person, a patient coordinator takes enquiries by phone at 905-276-5999.

Cost sits underneath this whole question. Bariatric surgery at The Sleeve Clinic is private-pay and is not covered by OHIP. Publicly funded bariatric surgery exists in Ontario through the Ministry of Health-funded Ontario Bariatric Network, which has a central referral route and its own wait times, and asking your family physician about that pathway is reasonable.

What surgery costs and how financing works

Frequently asked questions

How long do you have to stay on a GLP-1 medication?

There is no fixed course length. Canadian guidelines recommend that obesity medication be used long term when it is effective, as medication for blood pressure or cholesterol is. How long applies to you is a decision for you and your prescriber, reviewed over time.

What happens if I stop taking it?

Appetite regulation returns to how it worked before, usually within weeks of the last dose, and weight tends to follow over the months after. In trials of both semaglutide and tirzepatide, most participants who stopped regained a substantial share of what they had lost within a year, with wide variation between individuals.

Is being on a GLP-1 long term the same as being dependent on it?

No. These medications are not habit-forming in the way that word implies. Needing ongoing treatment is a feature of chronic conditions, not of these drugs specifically.

Can I take a lower dose to maintain my weight loss?

The published research looks at spacing injections further apart at the same dose, not at lowering the dose, and it amounts to a two-patient report and a series of 30 people. There are no established protocols yet. Any change to a dose or a schedule is a decision for your prescriber, never something to adjust independently.

Is it safe to take a GLP-1 for years?

Semaglutide and liraglutide have been used for type 2 diabetes for well over a decade, and weight-management trials now extend to several years. Long-term safety continues to be studied. Specific risks, monitoring and contraindications belong with your prescriber and the Health Canada product monograph for your medication.

Does bariatric surgery mean I will never need medication again?

No treatment for obesity removes the possibility of regain, and some people use weight-management medication after surgery. For the clinic's own surgical patients, that medication is prescribed and managed as part of follow-up. If your sleeve was performed at another centre, that follow-up belongs with the team that operated on you. Surgery changes the terms of long-term management rather than ending it.

Can I be assessed for surgery while I am taking a weight-loss medication?

Being on a weight-management medication does not by itself rule anything in or out. Bring the details to the consultation: which medication, the dose, how long you have taken it and how you responded. All of it is relevant. If the medication has already brought your weight down, the assessment weighs your current BMI together with the highest BMI you have documented and how your weight moved between the two. Should you go on to surgery, The Sleeve Clinic asks that the medication be stopped at least two weeks before the operation.

More common questions are answered here.

Before you act on any of this

This is general education, not personal medical advice. It cannot tell you whether to continue, change or stop a medication, or whether surgery is appropriate for you. Those decisions depend on an individual assessment, because the benefits, risks and alternatives differ for every person. Do not stop or adjust a prescribed medication based on anything you read here, particularly if it is also treating type 2 diabetes, where stopping can affect blood sugar control and other medications may need adjusting at the same time. Speak with the clinician who prescribed it. If you have urgent symptoms, contact your physician or local emergency services rather than relying on a blog.

The Sleeve Clinic is a private-pay bariatric practice led by Dr. Scott Gmora, MD, FRCSC, FACS, seeing patients in Toronto and across the GTA in person and elsewhere in Canada by virtual consultation. Alongside sleeve gastrectomy, the clinic prescribes and co-manages weight-management medication.

About Dr. Scott Gmora

If you want to think it through with someone

If you are on a GLP-1 and trying to work out what the next few years look like, you are welcome to book a consultation. The first call is free, takes about 15 to 20 minutes, and is with Mandy, the clinic's program advisor, rather than with the surgeon. It is a conversation rather than a commitment, with zero pressure attached. The Sleeve Clinic prescribes and co-manages weight-management medication as well as performing surgery, so continuing on medication — or restarting one you have already stopped — is a plan the consultation can end in, not a reason to skip it. A recommendation that you stay on medical treatment rather than have surgery is a legitimate outcome.

If you would rather start on your own, you can estimate a range with the weight-loss calculator first.

Individual results vary. Consult with Dr. Gmora for a personalized assessment.